Table 5.
s/n | Compound name | A | B | C | D | E | F | G | H |
---|---|---|---|---|---|---|---|---|---|
1 | STOCK1N-69160 | − | − | − | − | − | + | − | − |
2 | STOCK1N-68604 | − | − | − | − | + | + | + | + |
3 | STOCK1N-66718 | − | − | − | + | + | + | + | + |
4 | STOCK1N-69717 | − | − | − | − | − | + | + | + |
5 | STOCK1N-84011 | − | − | − | + | + | + | + | + |
6 | STOCK1N-59841 | − | − | − | − | + | + | + | + |
7 | STOCK1N-67398 | − | − | − | + | + | + | + | + |
8 | STOCK1N-65477 | − | − | − | − | − | + | + | + |
Active = ( +); Inactive = (−)
A = Carcinogenicity
B = Eye corrosion
C = Eye irritation
D = Ames mutagenesis
E = Micronuclear
F = Hepatotoxicity
G = Androgen receptor binding
H = PPAR gamma